Immediate Impact

2 from Science/Nature 67 standout
Sub-graph 1 of 24

Citing Papers

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
2022 Standout
Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial
2018 Standout
1 intermediate paper

Works of M. Shipley being referenced

A COMPARISON OF MEASURES OF HEALTH STATUS IN RHEUMATOID ARTHRITIS
1989

Author Peers

Author Last Decade Papers Cites
M. Shipley 114 45 23 111 58 12 380
S T Thio 185 37 15 50 98 9 416
Želmíra Macejová 166 28 47 52 33 25 399
Magdalen Fiddler 158 20 27 56 160 12 431
Melanie Sloan 94 15 7 132 23 25 432
Lampros Fotis 56 11 25 63 51 21 454
Birgitha Archenholtz 189 9 6 68 40 17 418
Joan Mendívil 31 10 43 94 15 15 426
Julie Bolen 99 24 4 45 10 9 346
Julie McLaughlin Gray 102 4 5 44 35 15 420
Susana Pedreiro 71 12 25 34 152 21 383

All Works

Loading papers...

Rankless by CCL
2026